Orot, Ricky C.

HRN: 27-35-43  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/21/2025
07/05/2025
IV
1.5G
Q6H
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines